Related references
Note: Only part of the references are listed.Incidence and prognostic significance of karyotypic subgroups in older patients with acute myeloid leukemia: the Swedish population-based experience
V. Lazarevic et al.
BLOOD CANCER JOURNAL (2014)
The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML
Sabine Kayser et al.
BLOOD (2011)
Risk stratification using a new prognostic score for patients with secondary acute myeloid leukemia: results of the prospective AML96 trial
F. Stoelzel et al.
LEUKEMIA (2011)
Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry
S. Lehmann et al.
LEUKEMIA (2011)
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
David Grimwade et al.
BLOOD (2010)
Cytogenetic findings in adult secondary acute myeloid leukemia (AML): frequency of favorable and adverse chromosomal aberrations do not differ from adult de novo AML
Birgitte S. Preiss et al.
CANCER GENETICS AND CYTOGENETICS (2010)
Reasons for treating secondary AML as de novo AML
Lene Sofie Granfeldt Ostgard et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry
Gunnar Juliusson et al.
BLOOD (2009)
Prognostic factor analysis of the survival of elderly patients with AML in the MRC AML11 and LRF AML14 trials
Keith Wheatley et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Outcomes of Patients Who Undergo Aggressive Induction Therapy for Secondary Acute Myeloid Leukemia
David A. Rizzieri et al.
CANCER (2009)
Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study
Anders Wahlin et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
Independent prognostic factors for AML outcome
D. Grimwade et al.
Hematology-American Society of Hematology Education Program (2009)
Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia?
Richard A. Larson
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2007)
Treatment of secondary acute myeloid leukemia
A Pulsoni et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML
C Schoch et al.
LEUKEMIA (2004)
AML with 11q23/MLL abnormalities as defined by the WHO classification:: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases
C Schoch et al.
BLOOD (2003)
Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series
SM Smith et al.
BLOOD (2003)
The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial
D Grimwade et al.
BLOOD (2001)
Clinical and biological features of acute myeloid leukaemia occurring as second malignancy: GIMEMA archive of adult acute leukaemia
L Pagano et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Share Paper
